Analgecine: Difference between revisions
Appearance
Content deleted Content added
←Created page with ''''Analgecine''' (brand name '''AGC''') is an analgesic extract that is approved for the treatment of back pain and neuralgia in China.<ref n...' |
discontinued |
||
(7 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
'''Analgecine''' (brand name '''AGC''') is |
'''Analgecine''' (brand name '''AGC''') is discontinued<ref name="AdisInsight">{{cite web | last=Name | first=Drug | title=Analgecine - Vanway Pharmaceutical | publisher=AdisInsight | date=2 October 2021 | url=https://adisinsight.springer.com/drugs/800040908|quote=29 Sep 2021 Discontinued - Phase-III for Neuropathic pain in China (Infusion)}}</ref> [[extracts]] of ''[[Vaccinia]]''-[[Inoculation|inoculated]] rabbit skin used as an [[analgesic]], that had been approved for the treatment of [[back pain]] and [[neuralgia]] in China.<ref name="AdisInsight"/><ref name="DongTu2016">{{cite journal|last1=Dong|first1=Jian|last2=Tu|first2=Hung-Ping|last3=Ding|first3=Wen-Yuan|last4=Ding|first4=Yue|last5=Li|first5=Jin|last6=Zhang|first6=Xue-Li|last7=Fan|first7=Cun-Yi|last8=Dong|first8=Hai-Long|last9=Wu|first9=Yi-Chia|last10=Wang|first10=Sebrina Su-Jung|last11=Lin|first11=Chen-Lung Steve|title=Analgecine, the extracts of Vaccinia-inoculated rabbit skin, effectively alleviates the chronic low back pain with little side effect – A randomized multi-center double-blind placebo-controlled phase 3 clinical trial|journal=Contemporary Clinical Trials Communications|volume=2|year=2016|pages=16–24|issn=2451-8654|doi=10.1016/j.conctc.2015.11.002|doi-access=free|pmid=29736443|pmc=5935851}}</ref> |
||
==References== |
==References== |
||
Line 5: | Line 5: | ||
==External links== |
==External links== |
||
* {{cite web | publisher=Vanway | title=Analgecine | date=2014 | url=http://www.vanworld-pharmaceutical.com/analgecine/ | archive-url=https://web.archive.org/web/20210417091638/http://www.vanworld-pharmaceutical.com/analgecine/ | archive-date=17 April 2021 | url-status=dead}} |
|||
* [http://adisinsight.springer.com/drugs/800040908 Analgecine - AdisInsight] |
|||
* [http://www.vanworld-pharmaceutical.com/analgecine/ Analgecine - Vanway] |
|||
{{Analgesics}} |
{{Analgesics}} |
Latest revision as of 15:44, 9 July 2023
Analgecine (brand name AGC) is discontinued[1] extracts of Vaccinia-inoculated rabbit skin used as an analgesic, that had been approved for the treatment of back pain and neuralgia in China.[1][2]
References
[edit]- ^ a b Name, Drug (2 October 2021). "Analgecine - Vanway Pharmaceutical". AdisInsight.
29 Sep 2021 Discontinued - Phase-III for Neuropathic pain in China (Infusion)
- ^ Dong, Jian; Tu, Hung-Ping; Ding, Wen-Yuan; Ding, Yue; Li, Jin; Zhang, Xue-Li; Fan, Cun-Yi; Dong, Hai-Long; Wu, Yi-Chia; Wang, Sebrina Su-Jung; Lin, Chen-Lung Steve (2016). "Analgecine, the extracts of Vaccinia-inoculated rabbit skin, effectively alleviates the chronic low back pain with little side effect – A randomized multi-center double-blind placebo-controlled phase 3 clinical trial". Contemporary Clinical Trials Communications. 2: 16–24. doi:10.1016/j.conctc.2015.11.002. ISSN 2451-8654. PMC 5935851. PMID 29736443.
External links
[edit]- "Analgecine". Vanway. 2014. Archived from the original on 17 April 2021.